The State Licensing Authority of Uttarakhand has granted license for Coronil tablet to be used as supporting measure in the management of Covid-19 without claiming cure following the advice of a review committee set up by the AYUSH ministry, the Lok Sabha was informed on Friday. Minister of State for Health Bharati Pravin Pawar, in a written reply, said the Interdisciplinary Technical Review Committee (ITRC) setup by the AYUSH ministry reviewed the application submitted by the Patanjali Research Foundation Trust for “updating the AYUSH license for Divya Coronil tablet” from ‘immunity booster’ to ‘medicine for COVID-19’.
The committee suggested that the tablet may be used as supporting measure in Covid management, she said. “The application titled ‘Updating AYUSH license for Divya Coronil tablet from Immunity booster to Medicine for Covid-19’ submitted by Patanjali Research Foundation Trust, Haridwar, Uttarakhand to this Ministry, was placed before the ITRC on October 27, 2020 for examination of the applications/claims on patent and propriety (P&P) ASU&H medicines with new indications or repurposing of licensed P&P, ASU&H medicines for Covid-19,” Pawar said in her reply.
The Section 3(a) and Section 3(h) define all Ayurvedic, Siddha, Unani medicines intended for internal or external use for or in the diagnosis, treatment, mitigation or prevention of diseases or disorder in human beings or animals, and manufactured exclusively in accordance with the formulae described in, the authoritative books of Ayurvedic, Siddha and Unani Tibb systems of medicine, specified in the First Schedule.
News Source : Economic Times
